ICON Announces the Expansion of its Accellacare Site Network – 10.11.2021

ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, today announced that its Accellacare Site Network has expanded in reach and capabilities through new partnerships with six research sites across four countries.

Read the source article at Aktien
2021-11-10 13:02:00